Related Experiment Video
Updated: May 4, 2026

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
Published on: January 27, 2023
Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO)
Christian M Hedrich1, Sigrun R Hofmann, Jessica Pablik
1Division of Pediatric Rheumatology and Immunology, Children's Hospital Dresden, University Medical Center Carl Gustav Carus, TU Dresden, Dresden, Germany. Christian.hedrich@uniklinikum-dresden.de.
Sterile bone inflammation characterizes autoinflammatory osteopathies like chronic recurrent multifocal osteomyelitis (CRMO). This review explores their pathophysiology, clinical features, and treatments, highlighting CNO/CRMO
Area of Science:
- Immunology
- Rheumatology
- Genetics
Background:
- Autoinflammatory bone disorders, including chronic nonbacterial osteomyelitis (CNO) and its severe form chronic recurrent multifocal osteomyelitis (CRMO), are characterized by sterile bone inflammation.
- These conditions arise from a dysregulated innate immune system, leading to bone inflammation and osteoclast activation, and are often linked to skin or intestinal inflammation.
- While some monogenic forms have identified genetic mutations, the molecular basis of CNO/CRMO remains largely unknown.
Purpose of the Study:
- To review the clinical presentation and molecular pathophysiology of human autoinflammatory osteopathies.
- To discuss findings from animal models relevant to these disorders.
- To focus specifically on chronic recurrent multifocal osteomyelitis (CRMO) and chronic nonbacterial osteomyelitis (CNO).
Main Methods:
- Literature review of clinical presentations and molecular pathophysiology.
- Analysis of data from human autoinflammatory osteopathies.
- Examination of relevant animal models.
Main Results:
- Autoinflammatory osteopathies involve sterile bone inflammation due to innate immune dysregulation.
- CNO/CRMO pathogenesis is complex and not fully elucidated.
- Associated conditions include skin and intestinal inflammation.
Conclusions:
- Understanding the molecular pathophysiology of CNO/CRMO is crucial for effective treatment.
- Treatment strategies for monogenic autoinflammatory bone disorders and CRMO are discussed.
- Further research is needed to clarify the molecular mechanisms underlying CNO/CRMO.
More Related Videos
07:51Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
Published on: March 18, 2019
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Bone Remodeling